Marcel Wüethrich, PhD, was recently received a research project grant (R01) from the National Institutes of Health – National Institute of Allergy and Infectious Diseases. This award of approximately $2.2 million in total cost is for his 5-year project, “Regulation of vaccine-induced anti-fungal T17 cells.” This project aims to provide new insight into the fungal pathogen recognition receptors and downstream signaling pathways, as well as the pathogen-associated molecular patterns that induce T17 cell differentiation. This knowledge will provide the fundamental basis for developing and designing new vaccine strategies against fungi, and will catalyze the discovery of novel adjuvants useful in vaccines against fungi and microbes in general.